These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1514 related items for PubMed ID: 11136258

  • 1. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW, Justement JS, Moir S, Hallahan CW, Ehler LA, Liu S, McLaughlin M, Dybul M, Mican JM, Fauci AS.
    Proc Natl Acad Sci U S A; 2001 Jan 02; 98(1):253-8. PubMed ID: 11136258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antigen-specific beta-chemokine production and CD8 T-cell noncytotoxic antiviral activity in HIV-2-infected individuals.
    Ahmed RK, Norrgren H, da Silva Z, Blaxhult A, Fredriksson EL, Biberfeld G, Andersson S, Thorstensson R.
    Scand J Immunol; 2005 Jan 02; 61(1):63-71. PubMed ID: 15644124
    [Abstract] [Full Text] [Related]

  • 5. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
    Fondere JM, Petitjean G, Huguet MF, Salhi SL, Baillat V, Macura-Biegun A, Becquart P, Reynes J, Vendrell JP.
    J Virol; 2004 Oct 02; 78(19):10536-42. PubMed ID: 15367620
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute human immunodeficiency virus replication causes a rapid and persistent impairment of Vgamma9Vdelta2 T cells in chronically infected patients undergoing structured treatment interruption.
    Martini F, Poccia F, Goletti D, Carrara S, Vincenti D, D'Offizi G, Agrati C, Ippolito G, Colizzi V, Pucillo LP, Montesano C.
    J Infect Dis; 2002 Sep 15; 186(6):847-50. PubMed ID: 12198622
    [Abstract] [Full Text] [Related]

  • 8. Absence of favourable changes in circulating levels of interleukin-16 or beta-chemokine concentration following structured intermittent interruption treatment of chronic human immunodeficiency virus infection.
    Montes de Oca Arjona M, Pérez Cano R, Orozco MJ, Martín Aspas A, Guerrero F, Fernández Gutiérrez Del Alamo C, Girón-González JA.
    Clin Microbiol Infect; 2005 Jan 15; 11(1):57-62. PubMed ID: 15649305
    [Abstract] [Full Text] [Related]

  • 9. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 15; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 10. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P, Joos B, Niederöst B, Weber R, Günthard HF, Fischer M.
    J Virol; 2007 Sep 15; 81(18):9693-706. PubMed ID: 17609262
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F, Mezzaroma I.
    AIDS Rev; 2006 Sep 15; 8(2):88-97. PubMed ID: 16848276
    [Abstract] [Full Text] [Related]

  • 13. A pilot study to assess inflammatory biomarker changes when raltegravir is added to a virologically suppressive HAART regimen in HIV-1-infected patients with limited immunological responses.
    Lichtenstein KA, Armon C, Nagabhushanam V, Efaw BJ, Frazer-Abel A, Hiserote ME, Alam R.
    Antivir Ther; 2012 Sep 15; 17(7):1301-9. PubMed ID: 22948290
    [Abstract] [Full Text] [Related]

  • 14. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients.
    Bouchat S, Gatot JS, Kabeya K, Cardona C, Colin L, Herbein G, De Wit S, Clumeck N, Lambotte O, Rouzioux C, Rohr O, Van Lint C.
    AIDS; 2012 Jul 31; 26(12):1473-82. PubMed ID: 22555163
    [Abstract] [Full Text] [Related]

  • 15. Characteristics of HIV-1-specific CD8 T-cell responses and their role in loss of viremia in children chronically infected with HIV-1 undergoing highly active antiretroviral therapy.
    Zhang Z, Zhao QX, Fu JL, Yao JX, He Y, Jin L, Wang FS.
    Chin Med J (Engl); 2006 Dec 05; 119(23):1949-57. PubMed ID: 17199938
    [Abstract] [Full Text] [Related]

  • 16. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
    Almeida M, Cordero M, Almeida J, Orfao A.
    Cytometry B Clin Cytom; 2007 Jan 15; 72(1):22-33. PubMed ID: 17051525
    [Abstract] [Full Text] [Related]

  • 17. Low-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.
    Sedaghat AR, Siliciano RF, Wilke CO.
    BMC Infect Dis; 2008 Jan 02; 8():2. PubMed ID: 18171475
    [Abstract] [Full Text] [Related]

  • 18. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.
    Chun TW, Davey RT, Ostrowski M, Shawn Justement J, Engel D, Mullins JI, Fauci AS.
    Nat Med; 2000 Jul 02; 6(7):757-61. PubMed ID: 10888923
    [Abstract] [Full Text] [Related]

  • 19. C-C chemokines, IL-16, and soluble antiviral factor activity are increased in cloned T cells from subjects with long-term nonprogressive HIV infection.
    Scala E, D'Offizi G, Rosso R, Turriziani O, Ferrara R, Mazzone AM, Antonelli G, Aiuti F, Paganelli R.
    J Immunol; 1997 May 01; 158(9):4485-92. PubMed ID: 9127015
    [Abstract] [Full Text] [Related]

  • 20. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF, Price P, French MA.
    HIV Med; 2005 Jul 01; 6(4):278-83. PubMed ID: 16011533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.